Short $HTBX Irrational HypeOh., how great... management bought some stock at $0.75 and they took back a public offering. The stock climbed and has momentum, but why? The company is still producing revenues of $0 and ops are getting more expensive. Earnings keep getting more negative, don't expect anything good to come out of their reporting coming up in August. Short at ~1.15 this morning and exit back at the 50-day moving average of $0.70-0.-75 in a few days. NASDAQ:HTBX
Healthcare
Ligand Pharmaceuticals best choise in the Biopharma IndustryFundamentals :
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing and acquiring technologies that help pharmaceutical companies discover and develop medicines worldwide. Ligand Pharmaceuticals has a compelling business model that offers higher than average return with lower than average risk.
Ligand's P/E of 8 is cheap as I mentioned. Forward P/E is indeed higher compared to the industry but I think it is still in range. Even if it is expensive, I think it is justified given the high return to equity that Ligand has generated in 2015. And as a growth stock, Ligand's growth comes at a cheaper price compared to the industry as represented by PE/G. So, do I think Ligand's a buy at this level? I think so
Technicals :
Price broke important level of resistance at $112 and had a nice run to $132. No we are in pullback, restesting previous resistance that now can act like support. And looks like we are curling up and can see new highs soon
Trade and Risk management:
We already have an initial entry, as price came out of consolidation above $121.40. I will initiate small position here with stop below $114.50 and will see if it can build new construction in front of high at $131.85 ot add to my position.
Amedisys has more room to runFundamentals :
Amedisys provides home health, and hospice and personal care services. The market Amedisys serves is expected to grow in the future. The company's earnings growth has averaged 46.3% over the past three years, while the industry has seen its bottom line increase at a far lesser rate of 3.2%. With the macro environment proving favorable for Amedisys, this trend is expected to sustain ahead.
Technicals :
Price is near all time highs, building a nice and narrow pattern. Price is above all key moving averages.
Trade and Risk management:
Break out of triangle will trigger an Entry Long around $54.30. Stop will be below $48.50 and respective target at $65
Medtronic rising to the sky Fundamentals :
It's not every day that you find a solid company operating in a growing industry which also happens to be a dividend aristocrat. Medtronic is such a company. Company is operating in the healthcare industry, being the largest medical technology company in the world. Today before market open company releases tis earnings report.
Technical :
Price broke up and holds above important resistance level $79. Price above all key moving averages.
Trade and Risk management :
Break above $82 will trigger Entry Long with stop below $80.60 and target around $88
Healthcare,biotech, pharmaceuticals stocks looking AttractiveMoney flow is at the lowest point of 2016 attract
Canopy Growth Corp. Stock PricesThis shows the stock prices of Canada's largest medical marijuana company.
Canopy Growth Corp. Stock Prices This tracks Canada's largest medical marijuana company's stock prices.
XLV ShortYou can thank that little price hiking hedge fund manager and people like Bill Ackman for the Healthcare/Pharmaceutical correction. Looking at the weekly using Fibs as reference points i believe healthcare over the next few months will begin to sell. I have a target of the 1.618 extension of 59.76 and a second target of 53.31. I'm using XLV to short because everything else is too expensive... you can play this through ITM puts or buy a longterm out of the money put at a 62 or 60 strike for next year.
Feel free to leave comments or questions.
-Ryanhasoptions.
Johnson & Johnson vs USDJohnson & Johnson has seen extreme price consolidation since last November. Since they are a highly diversified healthcare company, currency translations affect their bottom line quite substantially. With the recent contraction of the US Dollar, Johnson & Johnson has broken out of a prolonged trading range. If the dollar continues to contract against other foreign currencies, Johnson & Johnson will make better on their hedges and increase the bottom line substantially, thus increasing free cash flow and overall economic opportunity.
On Break LongXLV could move nicely as the healthcare stocks continue to advance, watch for a breakout with volume to take the trade and stop 8% down
Almost Family Does 38.2% RetracementAlmost Family has done a 38.2% Fibonacci Retracement.
Almost Family has grown EPS by +1340% quarter over quarter, and EPS forecasts for this company are rising fast.
This company has had an EPS surprise for the last 8 quarters!
The company has an excellent P/S of 0.8.
The catalyst for growth is that Americans are living longer and that means more home health care services are needed.
According to a 2014 report by Transparency Market Research, the global home health care market is expected to explode to $303.6 billion in 2020, up from $176.1 billion in 2013, growing at a compound rate of more than 8% per year.
Source: www.guerillastocktrading.com
Risk Averse Market - 2015 First and Second quartersWhat I am not showing here is, that the Cyclicals are losing steam, Sensitive Market is in neutral trend, Defensive has been the buyers paradise since OCT 2014.
Why I think that this can be called as a Biotech Bubble is because, It has done the same exact thing Financials did in 2007. ie., Moved tooo quick tooo far.
Yes Bio Tech (Healthcare) sector is a defensive sector, but this is not "the normal" on a defensive sector.
What could fuel this bubble burst ? That's up to the Govt, and the Medical Insurances out there. Most Medical Insurance at this point is so frustrated with the high Drug / Healthcare provider prices.
////////////////////
Note : This is not a Doom and Gloom Idea to trade. Its just my opinion - I am personally taking cautious actions with the market, that is reducing the risk to 1% or under in a trade. And focus on the Strong and Weak Sectors, Rather than the mixed bag.
This may not happen until second quarter of 2015, or even mid 2015. While the trend is up, I am still bullish. Until there is a transition.
Related Ideas - Show how trend changes again IMO.
Weekly Cup and Handle showing promiseA cup and handle pattern can result in strong price movement. Enter a small position and scale in if volume continues to follow through.
Long Mckesson CorpThe Healthcare Providers industry is one of the top performing industries in the strongest Sector in the S&P500, Healthcare. McKesson Corp is in a clear uptrend and has been gaining momentum as the relative performance chart indicates it has been ourperfoming the S&P more and more.
The recent Bollinger Squeeze on the Weekly chart suggests there could be a breakout to new highs. Any break of the uptrend should be an exit signal as the stock may start correcting.
